Startup aims to mend doctors’ social media woes
RepuChek software tracks, analyzes what’s being said about doctors on the Internet.
Health Care & Life Sciences
Articles
Lilly fights view that fate hinges on Alzheimer’s drug
Analysts have eyes on trial data for drug that could be a game-changer for the company.
Dow Agro improves quarterly revenue, profit
Indianapolis-based Dow AgroSciences on Thursday reported record third-quarter sales of $1.2 billion, up 27 percent from the same period a year ago.
Drug theft is ongoing battle for pharmacies
Over the last 12 months, the Indiana Board of Pharmacy has conducted license litigation involving at least 35 pharmacy personnel statewide who’ve been accused of stealing drugs from work.
WellPoint’s 3rd-quarter profit falls, but beats analyst estimates
WellPoint earned $683.2 million in the third quarter, down 7.6 percent from the same quarter a year ago. But the company boosted its per-share profit forecast for the rest of the year.
CNO Financial’s quarterly earnings, revenue rise
Carmel-based life and health insurer CNO Financial Group Inc. said Tuesday that its third-quarter earnings jumped nearly four times over last year's third-quarter results, but mostly because of a one-time tax-related gain.
FDA approves first generic versions of Zyprexa
Federal health officials on Monday approved the first generic versions of the blockbuster drug Zyprexa, which posted sales of $5.7 billion last year for Indianapolis-based drugmaker Eli Lilly and Co Inc.
Lilly: Vendors key after Zyprexa patent loss
Lilly’s patent-loss challenges—the biggest of which takes effect today—will force the company to rely even more on its 1,300 Indiana vendors.
WellPoint competitor Cigna buying HealthSpring
Cigna Corp. will buy fellow health insurer HealthSpring Inc. in a $3.8 billion deal as it becomes the latest managed care company to snap up a bigger share of the fast-growing Medicare Advantage market.
Insurance mandate lacks teeth, WellPoint CFO says
As constitutional challenges to the health reform law’s mandate to buy insurance advance, WellPoint Inc.’s chief financial officer reiterated that the company does not object to the mandate, just to its lack of penalties.
Hospitals scrambling to buy nursing homes
The hospitals owned by Boone and Hamilton counties are following the lead of Indianapolis-based Wishard Health Services and its parent organization by acquiring far-flung nursing homes, hoping the strategy proves as lucrative.
BioCrossroads seeds upstart medical device maker
BioCrossroads’ Indiana Seed Fund has invested $300,000 in a startup company chaired by a former Eli Lilly and Co. executive developing an absorbable stent.
Profit falls at Lilly but meets Wall Street expectations
The Indianapolis-based drugmaker earned $1.24 billion in the three months ended Sept. 30, down 5 percent from the same quarter a year ago, even as revenue surged 9 percent.
Lilly diabetes drug wins approval for expanded use
Eli Lilly and Co. and Amylin Pharmaceuticals Inc.’s Byetta has received expanded approval for use with the world’s top-selling insulin to treat Type 2 diabetes.
Officials urge Indiana Planned Parenthood to split up
Indiana officials contend the state's Planned Parenthood chapter could end a fierce legal dispute over abortion funding by simply separating its abortion business from other services.
Real estate brokerage sues IU Health over commissions
CBRE Inc. accuses the local hospital system of cheating it out of consulting fees that could top seven figures related to several building projects.
Ex-Dow Agro scientist pleads guilty in espionage case
Kexue Huang faces up to 13 years in prison after pleading guilty Tuesday morning to sending trade secrets worth millions to China and Germany.
Judge slaps IU Health over billing
The Indiana Court of Appeals reversed a Marion Superior Court decision to dismiss a lawsuit by two uninsured patients who received care at IU Health North Hospital in Carmel.
Deficit committee could bite CNO
Medicare supplement policies are reportedly one of the targets of Congress’ special deficit-reduction committee—and that’s not good news for Carmel-based CNO Financial Group Inc.